Latest news
Loading news…
Bioceros
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Utrecht, The Netherlands Founded 2003 11-50 employees For Profit
Bioceros provides services related to the preclinical development of monoclonal antibodies and generation protein-producing cell lines.
Bioceros was acquired by Polpharma in 2016.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
7
Patents
0
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Active products
- 10
- Patents granted
- 0
- Trademarks
- 1
- IT spend
- $9M
Company Info
- Founded
- 2003
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- HQ
- Utrecht, The Netherlands
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jul 26, 2016
- Closed
- Jul 26, 2016
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 1.4
- Trend (90d)
- 0.8
Acquisitions by Bioceros
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Bioceros
CSO, Founder & Managing Director
7
professional contacts at Bioceros
Contact execs at Bioceros →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Bioceros
Loading news…
FAQs about Bioceros
People who checked this page also checked these
Sectors Bioceros invests & acquires in
Browse the full Acquirezy directory.